Kathie M Dalessandri. Show Affiliations »
Abstract
Mesh： See more » Ascorbic Acid/pharmacologyAscorbic Acid/therapeutic useCarnitine/pharmacologyCarnitine/therapeutic useCoronary Artery Disease/etiologyDiet, ReducingEstrogens/pharmacologyEstrogens/therapeutic useExerciseFemaleHumansHyperlipoproteinemia Type II/bloodHyperlipoproteinemia Type II/geneticsLipoprotein(a)/bloodMutationNiacin/pharmacologyNiacin/therapeutic useReceptors, LDL/geneticsRisk FactorsTamoxifen/pharmacologyTamoxifen/therapeutic use
Substances： See more » EstrogensLipoprotein(a)Receptors, LDLTamoxifenNiacinAscorbic AcidCarnitine
Year: 2002 PMID： 12052489 DOI： 10.1016/s0021-9150(02)00031-x
Source DB: PubMed Journal: Atherosclerosis ISSN： 0021-9150 Impact factor: 5.162